Status:
COMPLETED
Effects of Augmented Reality-based Rapid Blood Transfusion (Level-1®)
Lead Sponsor:
Samsung Medical Center
Conditions:
Equipment and Supplies
Augmented Reality
Eligibility:
All Genders
Phase:
NA
Brief Summary
The goal of this clinical trial is to compare the effectiveness of AR-based training with traditional guideline-based self-learning in practical nurses without prior Level-1® experience. The main ques...
Detailed Description
In critical situations like hypovolemic shock, nurses must master skills for using devices like the Level-1® rapid infusion system. However, limited exposure poses challenges. Augmented reality (AR) o...
Eligibility Criteria
Inclusion
- Willingness to participate voluntarily and understanding of the study's purpose.
- No prior experience with the Level-1® rapid infusion system.
Exclusion
- Failure to meet the inclusion criteria.
- Prior experience with the Level-1® rapid infusion system.
- Inability to comprehend the study's purpose or express voluntary participation.
- Inability to attend required training and evaluations.
Key Trial Info
Start Date :
July 17 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 5 2023
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT06506851
Start Date
July 17 2023
End Date
September 5 2023
Last Update
July 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 06351